MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in MiNK Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −6 vs. Q4 2024
- Shares held
- 63.0K
- −18.0K (−22.2%) vs. Q4 2024Converted for a 1-for-10 split
- Total value
- $544.2K
- −$20.7K (−3.7%) vs. Q4 2024
- New holders
- 2
- 4 more added
- Sold out
- 8
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 23,744 | $205.1K | 0.00% | +326+1.4% | AddedConverted for a 1-for-10 split |
| Longbow Finance SA | 16,667 | $144.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 11,254 | $97.3K | 0.00% | +1,643+17.1% | AddedConverted for a 1-for-10 split |
| BlackRock, Inc. | 8,778 | $75.8K | 0.00% | −50−0.6% | ReducedConverted for a 1-for-10 split |
| Wells Fargo & Company | 848 | $7.33K | 0.00% | −160−15.9% | ReducedConverted for a 1-for-10 split |
| Bank of America Corp | 757 | $6.54K | 0.00% | +553+271.3% | AddedConverted for a 1-for-10 split |
| UBS Group AG | 284 | $2.45K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 238 | $2.05K | 0.00% | +106+80.4% | AddedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 172 | $1.49K | 0.00% | −368−68.2% | ReducedConverted for a 1-for-10 split |
| Covestor Ltd | 104 | $1.00K | 0.00% | −1−0.9% | ReducedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 30 | $259 | 0.00% | −3−7.7% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 24 | $208 | 0.00% | −9−28.1% | ReducedConverted for a 1-for-10 split |
| BNP Paribas Arbitrage, SA | 23 | $199 | 0.00% | −2−6.9% | ReducedConverted for a 1-for-10 split |
| Northwestern Mutual Wealth Management Co | 18 | $156 | 0.00% | −1−5.3% | ReducedConverted for a 1-for-10 split |
| Game Plan Financial Advisors, LLC | 16 | $138 | 0.00% | −1−5.9% | ReducedConverted for a 1-for-10 split |
| Clearstead Advisors, LLC | 14 | $121 | 0.00% | +14 | New |
| Jones Financial Companies LLLP | 1 | $9 | 0.00% | +1 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,171−100.0% | Sold outConverted for a 1-for-10 split |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −5,068−100.0% | Sold outConverted for a 1-for-10 split |
| State Street Corp | 0 | $0 | 0.00% | −2,552−100.0% | Sold outConverted for a 1-for-10 split |
| Greenwich Wealth Management LLC | 0 | $0 | 0.00% | −1,081−100.0% | Sold outConverted for a 1-for-10 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,144−100.0% | Sold outConverted for a 1-for-10 split |
| Key Financial Inc | 0 | $0 | 0.00% | −4−100.0% | Sold outConverted for a 1-for-10 split |
| Allworth Financial LP | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-10 split |
| FMR LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-10 split |